As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids -- with pharmacists playing a key role in detecting drug diversion and identifyi
U.S. hospitals wait more than a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
The introduction of the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms -- DISARM -- Act -- by United States Senators Johnny Isakson (R-GA) and Bob Casey (D-PA) Tuesday represents an essential step toward addressing the growing threat of infections that are increasing
Certain Antidepressants Could Provide a Frontline Treatment for Multiple Infectious Diseases, Testing Shows
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicineand collaborators at other institutions.
Last year, South Africa became the first country to roll out a new anti-tuberculosis drug in its national program. This new drug, called bedaquiline, is the first new anti-tuberculosis drug to be developed in four decades.
A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.
Researchers at the Liverpool School of Tropical Medicine (LSTM)'s Centre for Drugs and Diagnostics, and University of Buea, Cameroon have developed new models of the tropical eye worm, Loa loa for the development of new drugs against filariasis.
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective.
Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Although neglected diseases account for 11 percent of the global disease burden, they are targeted by only a small proportion of the new drugs developed every year.